Understanding Biosimilar Insulins: Your Patients’ Future

Supported by an unrestricted educational grant from Gan & Lee

Chairs: Tina Vilsbøll (DNK), Lutz Heinemann (GER)

19:30 – 19:33IntroductionTina Vilsbøll (DNK)
19:33 – 19:43Biosimilar Insulin Manufacturing: Why the process is the product?Lutz Heinemann (GER)
19:43 – 19:53Why do patient and HCP perceptions about biosimilar insulin matter?Ji, Linong (CHN)
19:53 – 20:00Discussion and closureAll